SCHEMBL19988641

SCHEMBL19988641

CSc1ccccc1-c1ccc(Br)c2cccnc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.48
▸ KMT2A Q03164 5/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ APAF1 O14727 1/20 0.46
▸ TDP2 O95551 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ CASP3 P42574 1/20 0.46
▸ SENP8 Q96LD8 1/20 0.46
▸ SENP7 Q9BQF6 1/20 0.46
▸ SENP6 Q9GZR1 1/20 0.46
▸ SLC40A1 Q9NP59 2/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ TP53 P04637 2/20 0.40
▸ HSP90AA1 P07900 2/20 0.40
▸ USP2 O75604 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CKS1B P61024 1/20 0.38
▸ SKP2 Q13309 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988536 0.80 HTT (0.34) HTTKMT2AMEN1APAF1TDP2
SCHEMBL21155161 0.75 MAPT (0.45) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL16856525 0.74 KDM4E (0.39) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL19974112 0.73 KDM4E (0.39) HTTKMT2AALDH1A1MAPTCASP3
SCHEMBL31071774 0.71 KMT2A (0.50) HTTKMT2AMEN1APAF1TDP2
SCHEMBL196848 0.71 KMT2A (0.68) HTTKMT2AMEN1APAF1TDP2
SCHEMBL14951410 0.69 ALDH1A1 (0.44) HTTKMT2AALDH1A1MAPTCASP3
SCHEMBL15109935 0.69 NISCH (0.44) KMT2AMEN1ALDH1A1MAPTCASP3
SCHEMBL19988605 0.69 WEE1 (0.45) HTTMAPTKDM4ELMNANISCH
SCHEMBL29777336 0.69 KMT2A (0.59) HTTKMT2AMEN1APAF1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 HTT 695/4885KMT2A 2077/4885MEN1 3510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback